Vanguard Group’s Processa Pharmaceuticals PCSA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.01K | Hold |
|
|||||
2025
Q1 | $9.04K | Hold |
|
|||||
2024
Q4 | $21.7K | Hold |
|
|||||
2024
Q3 | $33.5K | Hold |
|
|||||
2024
Q2 | $54.7K | Hold |
|
|||||
2024
Q1 | $57.8K | Buy |
|
|||||
2023
Q4 | $78.5K | Sell |
|
|||||
2023
Q3 | $86.2K | Sell |
|
|||||
2023
Q2 | $180K | Hold |
|
|||||
2023
Q1 | $181K | Sell |
|
|||||
2022
Q4 | $411K | Buy |
|
|||||
2022
Q3 | $845K | Buy |
|
|||||
2022
Q2 | $1.05M | Hold |
|
|||||
2022
Q1 | $1.13M | Hold |
|
|||||
2021
Q4 | $1.83M | Sell |
|
|||||
2021
Q3 | $3.2M | Buy |
|
|||||
2021
Q2 | $3.06M | Buy |
|
|||||
2021
Q1 | $1.72M | Buy |
|
|||||
2020
Q4 | $189K | Buy |
|